Editor's Note: These short reviews of a recent paper in the Journal, written exclusively by graduate students or postdoctoral fellows, are intended to mimic the journal clubs that exist in your own departments or institutions. For more information on the format and purpose of the Journal Club, please see http://www.jneurosci.org/misc/ifa_features.shtml. The actions of gonadal steroid hormones in the brain produce myriad physiological and behavioral effects. One of the most potent gonadal steroids is estradiol (E 2 ), which, in addition to positive and negative feedback effects on gonadotropinreleasing hormone release, affects sexual and social behavior, food intake, locomotor activity, and many other brain functions. The site(s) and the estrogen receptor (ER) species involved in most of these effects remain unknown. The vast majority of investigations have focused on the classical nuclear ERs, which are now known to have at least two subtypes, ER␣ and ER␤. Both ER␣ and ER␤ are present in the cytosol, membrane, or other cellular compartments and, after binding E 2 , initiate gene transcription by either nuclear translocation or activating secondmessenger pathways (Fig. 1) [Qiu et al. (2006) , their Fig. 3 
The actions of gonadal steroid hormones in the brain produce myriad physiological and behavioral effects. One of the most potent gonadal steroids is estradiol (E 2 ), which, in addition to positive and negative feedback effects on gonadotropinreleasing hormone release, affects sexual and social behavior, food intake, locomotor activity, and many other brain functions. The site(s) and the estrogen receptor (ER) species involved in most of these effects remain unknown. The vast majority of investigations have focused on the classical nuclear ERs, which are now known to have at least two subtypes, ER␣ and ER␤. Both ER␣ and ER␤ are present in the cytosol, membrane, or other cellular compartments and, after binding E 2 , initiate gene transcription by either nuclear translocation or activating secondmessenger pathways (Fig. 1) . Lagrange et al. (1997) identified a different, membrane-associated ER (mER) on hypothalamic neural membranes. Binding of E 2 to this mER results in increases in cAMP levels and rapid activation of phospholipase C/protein kinase C/protein kinase A (PLC/PKC/PKA) pathways that can immediately desensitize -opioid and GABA B receptors. In a recent issue of The Journal of Neuroscience, Qiu et al. (2006) reported exciting additional investigations of this mER.
The new results are based mainly on studies of the newly developed compound STX, a novel ER antagonist that does not bind to ER␣ or ER␤. Remarkably, ϳ75% of neurons in the hypothalamic arcuate nucleus, including all of the proopiomelanocortin (POMC)-expressing neurons, were found to be ϳ40% less sensitive to the GABA B agonist baclofen after STX treatment [Qiu et al. (2006) Because estradiol appears to play a physiological role in the regulation of eating, energy homeostasis, and adiposity in both animals and women (Geary, 2004; Asarian and Geary, 2006) , this functional conclusion deserves close scrutiny. Several issues require additional evaluation. First, of course, it will be important in future work to measure food intake directly, not just body weight. Although the effect of E 2 on energy homeostasis is mediated mainly by changes in food intake, effects on physical activity and metabolic energy expenditure can also be important, especially in rodents. Second, because STX was given systemically in the energy balance tests, the site of action is uncertain. Qiu et al. (2006) cite Butera and Cjaza (1984) to support the idea that the anorexigenic effects of E 2 originate in the arcuate/ventromedial hypothalamus; in fact, those authors found that paraventricular nucleus E 2 administration was more effective than arcuate administration. The same is true in rats (for review, see Geary, 2004) . Moreover, since that time, many investigators have shown that implantation of pure E 2 , as done by Butera and Cjaza (1984) , does not lead to a localized action of the hormone (for review, see Geary, 2004) . A third critical issue regards the involvement of ER␣ in body weight regulation: E 2 treatment does not normalize food intake or body weight gain in ER␣ KO mice (Geary et al., 2001) , indicating that ER␣ is necessary for this effect of E 2 . This, of course, does not eliminate the possibility that mER are also involved but does indicate that the relative contributions of the E 2 receptors require addi-tional work. A fourth and related point concerns the latency of the effect of E 2 on feeding in ovariectomized animals, which is normally over 24 h. For example, the subcutaneous injection of a physiological dose of E 2 (2 g) in ovariectomized rats does not affect food intake for over 1 d (Asarian and Geary, 2002) . This long latency seems inconsistent with the hypothesis that immediate mER signaling in the arcuate mediates the effect of E 2 on feeding. It is possible, of course, that other, slower effects of mER activation do contribute.
Finally, the hypothesis that hypothalamic melanocortinergic neurons are involved in the feeding-inhibitory effect of E 2 also deserves additional testing in light of several apparently inconsistent reports. For example, E 2 treatment failed to affect the feeding response to intracerebroventricular injections of either the melanocortin 3/4 receptor agonist melanotan II or the melanocortin 3/4 receptor antagonists SHU9119 ,Asp 5 ,D-2-Nal 7 ,Lys 10 )-cyclo-␣-MSH(4:10)amide] and agouti-related protein (for review, see Asarian and Geary, 2006) . If E 2 were to act, as hypothesized, by affecting the tone of hypothalamic melanocortinergic neurons, one would predict that E 2 would indirectly affect the response of their postsynaptic neurons to melanocortin 3/4 agonists or antagonists. Furthermore, the feeding-inhibitory effect of leptin, which directly activates arcuate melanocortinergic neurons, is also not affected by E 2 treatment in ovariectomized rats (for review, see Geary, 2004; Asarian and Geary, 2006) . Figure 1 . Schematic of intracellular mechanisms underlying E 2 effects on sexual and social behavior, energy homeostasis, and many other brain-mediated functions. Most of these functions occur as a result of gene transcription elicited by binding of E 2 to the classic ER␣ and ER␤. The newly characterized mER (Qiu et al., 2006 ) that seems to mediate some of the effects of E 2 on energy homeostasis opens new possibilities in the investigation of the role of E 2 in normal physiology.
